2019
DOI: 10.1007/s11154-019-09490-3
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence of retinopathy among type 2 diabetic patients in Iran: A systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
2

Year Published

2019
2019
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(14 citation statements)
references
References 32 publications
0
12
2
Order By: Relevance
“…In a cross-sectional Tunisian clinic-based study of 2320 adults, the prevalence of DR was 26.3%, out of whom 3.4% had proliferative DR and 4.2% had clinically significant macular edema[ 102 ]. In a systematic review in Iran which included 17079 individuals, the overall prevalence of DR was 37.8%, with wide variability among regions[ 103 ]. The prevalence of DR for the various countries is shown in Table 5 .…”
Section: Complications Of Diabetesmentioning
confidence: 99%
“…In a cross-sectional Tunisian clinic-based study of 2320 adults, the prevalence of DR was 26.3%, out of whom 3.4% had proliferative DR and 4.2% had clinically significant macular edema[ 102 ]. In a systematic review in Iran which included 17079 individuals, the overall prevalence of DR was 37.8%, with wide variability among regions[ 103 ]. The prevalence of DR for the various countries is shown in Table 5 .…”
Section: Complications Of Diabetesmentioning
confidence: 99%
“…Results of a study on T2D patients in China showed the prevalence of retinopathy was 34% [15]. Results of a meta-analysis study in Iranian population showed that the prevalence of retinopathy was about 38% among patients with T2D [16].…”
Section: Introductionmentioning
confidence: 98%
“…For instance, a study that focused on the Tehran subjects, evaluated the risk factors of diabetic retinopathy. By analysis, the authors found that among 8,000 enrolled subjects, about 10% of them presented diabetes, but the prevalence of hyperlipidemia had no obvious correlation with the risk of diabetic retinopathy [27,28]. Consistently, another large-scale clinical trial, called the Australian Diabetes, Obesity and Lifestyle Study (AusDiab Study), screened about 2,200 participants with diabetes mellitus and found that the circulating levels of LDL-C were not correlated with the development of diabetic retinopathy [29].…”
Section: Clinical Trials On Hyperlipidemia and Diabetic Retinopathymentioning
confidence: 99%